359 related articles for article (PubMed ID: 33518775)
1. Identification of potential inhibitors of SARS-CoV-2 main protease from
Mpiana PT; Ngbolua KT; Tshibangu DST; Kilembe JT; Gbolo BZ; Mwanangombo DT; Inkoto CL; Lengbiye EM; Mbadiko CM; Matondo A; Bongo GN; Tshilanda DD
Chem Phys Lett; 2020 Sep; 754():137751. PubMed ID: 33518775
[TBL] [Abstract][Full Text] [Related]
2. Exploring the active constituents of
Shah S; Chaple D; Arora S; Yende S; Moharir K; Lohiya G
Netw Model Anal Health Inform Bioinform; 2021; 10(1):8. PubMed ID: 33585155
[TBL] [Abstract][Full Text] [Related]
3. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
4.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
Abdusalam AAA; Murugaiyah V
Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
[TBL] [Abstract][Full Text] [Related]
6.
Belhassan A; Chtita S; Zaki H; Alaqarbeh M; Alsakhen N; Almohtaseb F; Lakhlifi T; Bouachrine M
J Mol Struct; 2022 Jun; 1258():132652. PubMed ID: 35194243
[TBL] [Abstract][Full Text] [Related]
7. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
[TBL] [Abstract][Full Text] [Related]
8. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
9. In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors.
Cetin A
Chem Phys Lett; 2021 May; 771():138563. PubMed ID: 33776065
[TBL] [Abstract][Full Text] [Related]
10. Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2.
Mohammad A; Zheoat A; Oraibi A; Manaithiya A; S Almaary K; Allah Nafidi H; Bourhia M; Kilani-Jaziri S; A Bin Jardan Y
Front Mol Biosci; 2023; 10():1306179. PubMed ID: 38516396
[No Abstract] [Full Text] [Related]
11.
Prabhakaran P; Hebbani AV; Menon SV; Paital B; Murmu S; Kumar S; Singh MK; Sahoo DK; Desai PPD
Front Microbiol; 2023; 14():1194794. PubMed ID: 37448573
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.
Chidambaram S; El-Sheikh MA; Alfarhan AH; Radhakrishnan S; Akbar I
Saudi J Biol Sci; 2021 Jan; 28(1):1100-1108. PubMed ID: 33199969
[TBL] [Abstract][Full Text] [Related]
13. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
14. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential M
Shaaban S; Abdou A; Alhamzani AG; Abou-Krisha MM; Al-Qudah MA; Alaasar M; Youssef I; Yousef TA
Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109441
[TBL] [Abstract][Full Text] [Related]
16. In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening.
Ghaleb A; Aouidate A; Ayouchia HBE; Aarjane M; Anane H; Stiriba SE
J Biomol Struct Dyn; 2022 Jan; 40(1):143-153. PubMed ID: 32799761
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.
Aouidate A; Ghaleb A; Chtita S; Aarjane M; Ousaa A; Maghat H; Sbai A; Choukrad M; Bouachrine M; Lakhlifi T
J Biomol Struct Dyn; 2021 Aug; 39(12):4522-4535. PubMed ID: 32552534
[TBL] [Abstract][Full Text] [Related]
18. Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.
Dey D; Dey N; Ghosh S; Chandrasekaran N; Mukherjee A; Thomas J
Virusdisease; 2021 Mar; 32(1):108-116. PubMed ID: 33842675
[TBL] [Abstract][Full Text] [Related]
19. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
20. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
